Clinical Trial Update: Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine

View source ↗

Summary

This document reports the completion of a cohort event monitoring study for Dengvaxia (CYD-TDV) dengue vaccine, describing safety observations gathered in the m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever
• Dengue Hemorrhagic Fever

Drugs mentioned

• Dengvaxia (CYD-TDV)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue Fever, Dengue Hemorrhagic Fever | Status: COMPLETED